Emer Simic recently discussed biotech trends related to intellectual property with Crain’s Chicago Business. In the article, “The Future of Biotech: Diving Into the Latest Trends in Life Sciences Patent Litigation” she unpacks recent developments in patent law regarding whether work-from-home arrangements in biotech could impact where patent lawsuits can be brought, and if a proposed law would solve the issues of Federal Circuit Judges’ need for clarification on what it means to be patent eligible. 

Click here to read the article.